☆ 4.6 Article

Use of the Wearable Cardioverter-Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Related references

Note: Only part of the references are listed.

Article Multidisciplinary Sciences

Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry

Ibrahim El-Battrawy et al.

Summary: Patients at high risk for sudden cardiac death may benefit from wearable cardioverter defibrillators by avoiding immediate implantable cardioverter defibrillator implantation. Factors such as patient selection, compliance, and drug treatment play important roles. This study presents real world data from Germany and Switzerland, analyzing outcome data and patient characteristics.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC)

Katja Zeppenfeld et al.

EUROPEAN HEART JOURNAL (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

Protected risk stratification with the wearable cardioverter-defibrillator: results from the WEARIT-II-EUROPE registry

Christian Veltmann et al.

Summary: The WEARIT-II-EUROPE registry demonstrated that in patients with heart failure and reduced left ventricular ejection fraction, the wearable cardioverter-defibrillator (WCD) can protect against progression of ejection fraction and evaluate competing risks of potential non-arrhythmic death, potentially improving the selection for beneficial implantation of an implantable cardioverter-defibrillator.

CLINICAL RESEARCH IN CARDIOLOGY (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Mortality and ventricular arrhythmia after acute myocarditis: a nationwide registry-based follow-up study

Kristian Hay Kragholm et al.

Summary: This nationwide study in Denmark found that patients hospitalized with acute myocarditis had significantly higher risks of all-cause mortality, heart failure, ventricular arrhythmias, cardiac arrest, and implantable cardioverter-defibrillator (ICD) implantation within 90 days compared to background population controls.

OPEN HEART (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Benefit of a wearable cardioverter defibrillator for detection and therapy of arrhythmias in patients with myocarditis

Verena Tscholl et al.

Summary: Myocarditis can lead to malignant arrhythmias and sudden cardiac death, with no reliable predictors currently available. This study aimed to evaluate the effectiveness of a wearable cardioverter defibrillator (WCD) in detecting and treating such arrhythmias in the peracute setting of myocarditis. The results showed that using a WCD after acute myocarditis could lead to the detection of sustained ventricular tachycardia in a small percentage of patients, impacting clinical management through monitoring and arrhythmia detection.

ESC HEART FAILURE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Wearable cardioverter-defibrillator: friend or foe in suspected myocarditis?

Florian Blaschke et al.

Summary: A total of 135 patients were analyzed, with 76 suspected myocarditis patients prescribed a WCD. 39 patients were diagnosed with myocarditis and impaired LVEF, while 37 patients had dilated cardiomyopathy without evidence of cardiac inflammation. The study suggests potential benefits of WCD therapy for myocarditis patients, but further randomized studies are needed for verification.

ESC HEART FAILURE (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Ventricular Arrhythmias in Myocarditis Characterization and Relationships With Myocardial Inflammation

Giovanni Peretto et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

High Risk of Sustained Ventricular Arrhythmia Recurrence After Acute Myocarditis

Laurent Rosier et al.

JOURNAL OF CLINICAL MEDICINE (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy An Expert Consensus Document

Enrico Ammirati et al.

CIRCULATION-HEART FAILURE (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Arrhythmias in myocarditis: State of the art

Giovanni Peretto et al.

HEART RHYTHM (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Wearable cardioverter defibrillator (WCD)-Indications and use Recommendations of the working group 1 of the German Cardiac Society (DGK)

T. Deneke et al.

KARDIOLOGE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society

Sana M. Al-Khatib et al.

CIRCULATION (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

A real world wearable cardioverter defibrillator experience - Very high appropriate shock rate in ischemic cardiomyopathy patients at a European single-center

Thomas Beiert et al.

JOURNAL OF ELECTROCARDIOLOGY (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Experience With the Wearable Cardioverter-Defibrillator in Patients at High Risk for Sudden Cardiac Death

Nadine K. Waessnig et al.

CIRCULATION (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients Data From the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry)

Valentina Kutyifa et al.

CIRCULATION (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)

Silvia G. Priori et al.

EUROPEAN HEART JOURNAL (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.